• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织蛋白酶H参与II型肺细胞中疏水性表面活性剂相关蛋白C的加工过程。

Involvement of cathepsin H in the processing of the hydrophobic surfactant-associated protein C in type II pneumocytes.

作者信息

Brasch Frank, Ten Brinke Anja, Johnen Georg, Ochs Matthias, Kapp Nadine, Müller Klaus M, Beers Michael F, Fehrenbach Heinz, Richter Joachim, Batenburg Joseph J, Bühling Frank

机构信息

Division of Electron Microscopy, Department of Anatomy, University of Göttingen, Germany.

出版信息

Am J Respir Cell Mol Biol. 2002 Jun;26(6):659-70. doi: 10.1165/ajrcmb.26.6.4744.

DOI:10.1165/ajrcmb.26.6.4744
PMID:12034564
Abstract

Surfactant protein C (SP-C) is synthesized by type II pneumocytes as a 21-kD propeptide (proSP-C) which is proteolytically processed to a 4.2-kD dipalmitoylated protein. To characterize the processing of proSP-C and the role of the cysteine protease cathepsin H, we studied the localization of proSP-C and cathepsin H in human as well as proSP-C in rat lungs, the enzymatic cathepsin H activity in isolated rat lamellar bodies, and the cleavage of human proSP-C by purified cathepsin H. Using antisera directed against the N-terminal E(11)-R(23) (NPROSP-C(11-23)), the C-terminal G(162)-G(174) domain (CPROSP-C(162-174)) of proSP-C, and against cathepsin H, immunogold labeling identified all three in electron-dense multivesicular bodies, but only NPROSP-C(11-23) and cathepsin H in composite as well as lamellar bodies of type II pneumocytes. Immuno double-labeling further distinguished electron-dense vesicles containing cathepsin H or electron light vesicles/multivesicular bodies containing proSP-C. Isolated lamellar bodies contained enzymatically active cathepsin H, a 6-kD proSP-C processing intermediate detected only by NPROSP-C(11-23), and mature SP-C. Using enzyme activities comparable to those in isolated lamellar bodies, purified cathepsin H generated a partially N-terminal processed proSP-C intermediate in vitro. In conclusion, our results indicate that after the fusion of electron-dense vesicles containing cathepsin H and electron-light vesicles or multivesicular bodies containing proSP-C, cathepsin H is involved in the first N-terminal processing step of proSP-C in electron-dense multivesicular bodies of type II pneumocytes.

摘要

表面活性蛋白C(SP-C)由II型肺细胞合成为一种21-kD的前体肽(proSP-C),该前体肽经蛋白水解加工成一种4.2-kD的二棕榈酰化蛋白。为了表征proSP-C的加工过程以及半胱氨酸蛋白酶组织蛋白酶H的作用,我们研究了proSP-C和组织蛋白酶H在人肺中的定位以及proSP-C在大鼠肺中的定位、分离的大鼠板层小体中的组织蛋白酶H酶活性,以及纯化的组织蛋白酶H对人proSP-C的切割。使用针对proSP-C的N端E(11)-R(23)(NPROSP-C(11-23))、C端G(162)-G(174)结构域(CPROSP-C(162-174))以及针对组织蛋白酶H的抗血清,免疫金标记在电子致密多囊泡体中鉴定出了这三者,但仅在II型肺细胞的复合小体和板层小体中鉴定出了NPROSP-C(11-23)和组织蛋白酶H。免疫双标记进一步区分了含有组织蛋白酶H的电子致密囊泡或含有proSP-C的电子淡囊泡/多囊泡体。分离的板层小体含有酶活性的组织蛋白酶H、仅由NPROSP-C(11-23)检测到的6-kD proSP-C加工中间体以及成熟的SP-C。使用与分离的板层小体中相当的酶活性,纯化的组织蛋白酶H在体外产生了一种部分N端加工的proSP-C中间体。总之,我们的结果表明,在含有组织蛋白酶H的电子致密囊泡与含有proSP-C的电子淡囊泡或多囊泡体融合后,组织蛋白酶H参与了II型肺细胞电子致密多囊泡体中proSP-C的首个N端加工步骤。

相似文献

1
Involvement of cathepsin H in the processing of the hydrophobic surfactant-associated protein C in type II pneumocytes.组织蛋白酶H参与II型肺细胞中疏水性表面活性剂相关蛋白C的加工过程。
Am J Respir Cell Mol Biol. 2002 Jun;26(6):659-70. doi: 10.1165/ajrcmb.26.6.4744.
2
Surfactant protein B in type II pneumocytes and intra-alveolar surfactant forms of human lungs.人肺II型肺泡上皮细胞和肺泡内表面活性物质形式中的表面活性蛋白B。
Am J Respir Cell Mol Biol. 2004 Apr;30(4):449-58. doi: 10.1165/rcmb.2003-0262OC. Epub 2003 Sep 11.
3
Post-translational processing of surfactant protein-C proprotein: targeting motifs in the NH(2)-terminal flanking domain are cleaved in late compartments.表面活性蛋白-C前体蛋白的翻译后加工:氨基末端侧翼结构域中的靶向基序在晚期区室中被切割。
Am J Respir Cell Mol Biol. 2001 Mar;24(3):253-63. doi: 10.1165/ajrcmb.24.3.4312.
4
Cysteine protease activity is required for surfactant protein B processing and lamellar body genesis.
Am J Respir Cell Mol Biol. 2003 Jan;28(1):69-79. doi: 10.1165/rcmb.2002-0111OC.
5
Involvement of napsin A in the C- and N-terminal processing of surfactant protein B in type-II pneumocytes of the human lung.napsin A参与人肺II型肺泡上皮细胞中表面活性蛋白B的C端和N端加工过程。
J Biol Chem. 2003 Dec 5;278(49):49006-14. doi: 10.1074/jbc.M306844200. Epub 2003 Sep 16.
6
Localization, synthesis, and processing of surfactant protein SP-C in rat lung analyzed by epitope-specific antipeptide antibodies.用表位特异性抗肽抗体分析大鼠肺表面活性物质蛋白SP-C的定位、合成及加工过程。
J Biol Chem. 1994 Aug 12;269(32):20318-28.
7
Expression and glucocorticoid regulation of surfactant protein C in human fetal lung.人胎肺表面活性物质蛋白C的表达及糖皮质激素调节
Pediatr Res. 1997 Sep;42(3):356-64. doi: 10.1203/00006450-199709000-00017.
8
Posttranslational processing of surfactant protein C in rat type II cells.
Am J Physiol. 1995 Dec;269(6 Pt 1):L727-33. doi: 10.1152/ajplung.1995.269.6.L727.
9
Synthesis and processing of hydrophobic surfactant protein C by isolated rat type II cells.
Am J Physiol. 1995 Dec;269(6 Pt 1):L744-53. doi: 10.1152/ajplung.1995.269.6.L744.
10
Processing of pulmonary surfactant protein B by napsin and cathepsin H.肺表面活性蛋白B被天冬氨酸蛋白酶和组织蛋白酶H的加工处理
J Biol Chem. 2004 Apr 16;279(16):16178-84. doi: 10.1074/jbc.M312029200. Epub 2004 Feb 6.

引用本文的文献

1
Surfactant protein SP-B: one ring to rule the molecular and biophysical mechanisms of the pulmonary surfactant system.表面活性蛋白SP-B:掌控肺表面活性物质系统分子与生物物理机制的关键一环。
Biophys Rev. 2025 Mar 18;17(2):653-666. doi: 10.1007/s12551-025-01285-y. eCollection 2025 Apr.
2
Targeting USP11 counteracts -associated interstitial lung disease in hiPSCs-derived alveolar organoids and in vivo models.靶向USP11可对抗人诱导多能干细胞衍生的肺泡类器官和体内模型中的特发性肺间质疾病。
Theranostics. 2025 Mar 19;15(10):4526-4549. doi: 10.7150/thno.105994. eCollection 2025.
3
The multifaceted roles of cathepsins in immune and inflammatory responses: implications for cancer therapy, autoimmune diseases, and infectious diseases.
组织蛋白酶在免疫和炎症反应中的多方面作用:对癌症治疗、自身免疫性疾病和传染病的影响。
Biomark Res. 2024 Dec 31;12(1):165. doi: 10.1186/s40364-024-00711-9.
4
Cathepsins and cancer risk: a Mendelian randomization study.组织蛋白酶与癌症风险:一项孟德尔随机化研究。
Front Endocrinol (Lausanne). 2024 May 31;15:1428433. doi: 10.3389/fendo.2024.1428433. eCollection 2024.
5
Mendelian randomization analyses explore the relationship between cathepsins and lung cancer.孟德尔随机化分析探讨组织蛋白酶与肺癌之间的关系。
Commun Biol. 2023 Oct 7;6(1):1019. doi: 10.1038/s42003-023-05408-7.
6
Novel opportunities from bioimaging to understand the trafficking and maturation of intracellular pulmonary surfactant and its role in lung diseases.从生物成像中探索新机遇,以了解细胞内肺表面活性剂的运输和成熟过程及其在肺部疾病中的作用。
Front Immunol. 2023 Aug 10;14:1250350. doi: 10.3389/fimmu.2023.1250350. eCollection 2023.
7
Rational engineering of lung alveolar epithelium.肺泡上皮的合理工程设计。
NPJ Regen Med. 2023 Apr 28;8(1):22. doi: 10.1038/s41536-023-00295-2.
8
Epigenome-wide association study of bronchopulmonary dysplasia in preterm infants: results from the discovery-BPD program.支气管肺发育不良的全基因组关联研究:来自发现-BPD 计划的结果。
Clin Epigenetics. 2022 Apr 28;14(1):57. doi: 10.1186/s13148-022-01272-0.
9
Patient-specific iPSCs carrying an SFTPC mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung disease.携带有 SFTPC 突变的患者特异性 iPSCs 揭示了间质性肺疾病起始时内在的肺泡上皮功能障碍。
Cell Rep. 2021 Aug 31;36(9):109636. doi: 10.1016/j.celrep.2021.109636.
10
Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation.II 型肺泡细胞 MHCII 改善呼吸道病毒病的预后,同时表现出有限的抗原呈递。
Nat Commun. 2021 Jun 28;12(1):3993. doi: 10.1038/s41467-021-23619-6.